US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
The Worlds Collective Consciousness
Foreign Over-Investment in the U.S.?
Blackrock Offers to Purchase Panama Canal Ports